Munich Leukemia Laboratory (Germany)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2015

  1. The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

    Blood Cancer Journal, Vol. 5

2011

  1. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

    Leukemia, Vol. 25, Núm. 1, pp. 110-120